BIOMAT Database Logo BIOMAT Database Logo

[Intravenous diazoxide treatment in serious hypertension]. 1975

L Westlie

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Westlie
Intravenous diazoxide for severe hypertension in childhood.
November 1971, The Journal of pediatrics,
L Westlie
Intravenous diazoxide in treatment of hypertension associated with recent myocardial infarction.
October 1975, British medical journal,
L Westlie
Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
February 1986, The Australian & New Zealand journal of obstetrics & gynaecology,
L Westlie
Intravenous diazoxide in the management of severe hypertension.
January 1980, The Journal of the Association of Physicians of India,
L Westlie
Diazoxide in treatment of hypertension.
September 1976, British medical journal,
L Westlie
Acute diabetic ketoacidosis--a complication of intravenous diazoxide treatment for refractory hypertension.
April 1969, The New England journal of medicine,
L Westlie
Safety of intravenous diazoxide in children with severe hypertension.
November 1979, Clinical pediatrics,
L Westlie
Diazoxide in the treatment of hypertension.
January 1962, The Journal of new drugs,
L Westlie
Diazoxide in the treatment of hypertension.
January 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
L Westlie
Management of severe hypertension with intravenous injections of diazoxide.
December 1969, The American journal of cardiology,
Copied contents to your clipboard!